U.S. investors take shine to U.K.’s BlueGem

  • Firm aims to raise $542.3 mln
  • Amount raised to date is $281.5 million
  • FirstPoint Equity is placement agent

U.S. investors have kicked in about $62 million out of a total of about $282 million raised for BlueGem II, the latest private equity pool from London-based BlueGem Capital Partners, according to a regulatory filing.

The firm reported a date of first sale of November 22, 2013, for BlueGem II LP, with a total amount sold of $61.5 million, which does not include $220 million of interests sold to non-U.S. investors, according to an amended Form D filing.

BlueGem executives did not return a call to the firm’s London office.

Marco Capello and Marco Anatriello co-founded BlueGem Capital in 2006 after working at Merrill Lynch. Capello was managing director of Merrill Lynch Global Private Equity, while Anatriello was a member of the Merrill Lynch investment banking team in Milan and London.

The firm’s first fund raised about 200 euros ($236 million), according to reports.

Among its high-profile deals, BlueGem bought London’s historic Liberty department store in 2010. In 2012, BlueGem paid an undisclosed sum to buy wine supplier Enotria Group.

Other portfolio companies include The Private Clinic, which operates a chain of cosmetic treatment clinics, Fintyre, a tire distributor, and Neomobile SpA, a mobile commerce company.